During the past decade, Institut Jean Godinot conducted 95 clinical trials. In the 10-year time frame, 95 clinical trials started and 18 clinical trials were completed, i.e. on average, 18.9% percent of trials that started reached the finish line to date. In the past 5 years, 50 clinical trials started and 10 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Institut Jean Godinot" #1 sponsor was "UNICANCER" with 61 trials, followed by "ARCAGY/ GINECO GROUP" with 14 trials sponsored, "Hoffmann-La Roche" with 12 trials sponsored, "Centre Leon Berard" with 11 trials sponsored and "Centre Jean Perrin" with 11 trials sponsored. Other sponsors include 86 different institutions and companies that sponsored additional 51 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Institut Jean Godinot" #1 collaborator was "National Cancer Institute, France" with 9 trials as a collaborator, "AstraZeneca" with 6 trials as a collaborator, "UNICANCER" with 6 trials as a collaborator, "Merck Sharp & Dohme LLC" with 5 trials as a collaborator and "Pfizer" with 5 trials as a collaborator. Other collaborators include 131 different institutions and companies that were collaborators in the rest 101 trials.

According to Clinical.Site data, the most researched conditions in "Institut Jean Godinot" are "Breast Cancer" (37 trials), "Prostate Cancer" (14 trials), "Ovarian Cancer" (10 trials), "Colorectal Cancer" (8 trials) and "Cancer" (7 trials). Many other conditions were trialed in "Institut Jean Godinot" in a lesser frequency.

Most popular intervention types in "Institut Jean Godinot" are "Drug" (135 trials), "Radiation" (28 trials), "Other" (27 trials), "Procedure" (26 trials) and "Biological" (15 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "fluorouracil" (11 trials), "radiation therapy" (11 trials), "Docetaxel" (9 trials) and "Trastuzumab" (9 trials). Other intervention names were less common.

The vast majority of trials in "Institut Jean Godinot" are 104 trials for "All" genders, 69 trials for "Female" genders and 24 trials for "Male" genders.

Currently, there are NaN active trials in "Institut Jean Godinot". 1 are not yet recruiting, 49 are recruiting, 26 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 96 completed trials in Institut Jean Godinot, 2 suspended trials, and 18 terminated clinical trials to date.

Out of the total trials that were conducted in Institut Jean Godinot, 3 "Phase 1" clinical trials were conducted, 61 "Phase 2" clinical trials and 79 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 31 trials that are defined as “Not Applicable".